Skip to main content
Clinical Trials/CTRI/2025/07/090835
CTRI/2025/07/090835
Not yet recruiting
Not Applicable

Role of Homoeopathic medicines in management of Allergic rhinitis in Paediatric age group - A clinical observational trial

Dr MPK Homoeopathic Medical College Hospital and Research Centre1 site in 1 country60 target enrollmentStarted: July 24, 2025Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Dr MPK Homoeopathic Medical College Hospital and Research Centre
Enrollment
60
Locations
1
Primary Endpoint
To assess the effectiveness of Homeopathic Medicines in cases of Allergic rhinitis by comparing the pre- and post- scores of Sino Nasal Outcome Test (SNOT-22).

Overview

Brief Summary

To manage the role of individualized homoeopathic medicine in cases of allergic rhinitis.

•        Null Hypothesis (H0) – Homoeopathic medicines are not effective in managing cases of Allergic Rhinitis in paediatric age group.

•        Alternate hypothesis (H1) – Homoeopathic medicines are effective in managing cases of Allergic Rhinitis in paediatric age group.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
5.00 Year(s) to 18.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Nose: sneezing, nasal congestion or blockage, nasal discharge (runny nose), and a scratchy palate and nose.
  • Eye: red eyes (concomitant allergic conjunctivitis), swollen eyes, and bilateral itching eyes.

Exclusion Criteria

  • Individuals who decline to consent to the study.
  • Patients who have been diagnosed with additional autoimmune and systemic diseases.
  • The situations that call for rescue or emergency care.

Outcomes

Primary Outcomes

To assess the effectiveness of Homeopathic Medicines in cases of Allergic rhinitis by comparing the pre- and post- scores of Sino Nasal Outcome Test (SNOT-22).

Time Frame: Pre score will be taken at the baseline of | treatment and post scores will be assessed at | the end of 3 months using Sino Nasal Outcome Test (SNOT-22)

Secondary Outcomes

  • To observe any changes in IgE level.(3 months)

Investigators

Sponsor
Dr MPK Homoeopathic Medical College Hospital and Research Centre
Sponsor Class
Private medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Kamal Nainawat

Dr. MPK Homoeopathic Medical College Hospital and Research Centre, Homoeopathy University

Study Sites (1)

Loading locations...

Similar Trials